ContentsSynopsisCodesDifferential Diagnosis & PitfallsBest TestsReferencesView all Images (2)
Glycogen storage disease type 3
Other Resources UpToDate PubMed

Glycogen storage disease type 3

Print Images (2)
Contributors: Marilyn Augustine MD
Other Resources UpToDate PubMed


Glycogen storage disease type 3 (Cori disease, Forbes disease, or limit dextrinosis) is an autosomal recessive disorder of glycogen debrancher enzyme deficiency. This causes the buildup of abnormal glycogen, which affects the function of the liver, heart, and skeletal muscles. Caused by mutations on the AGL gene. Most patients present with hepatomegaly and hypoglycemia in either infancy or by childhood. Otherwise, presentations can vary widely as the disease has 4 subtypes.

The most common subtype, glycogen storage disease type IIIa, represents patients with affected liver and muscles. Common findings for Type IIIa include seizures, hepatomegaly, hypotonia, ketoacidosis, and hypoglycemia. Type IIIb is second most common, primarily affecting the liver. These patients present with hypotonia, hepatomegaly, short stature, abdominal distension, cardiomyopathy, and hypoglycemia. Very rarely will patients present with types IIIc or IIId, which are characterized by absent activity from either glucosidase or transferase debranching activities.

Patients must eat a special diet to maintain normal glucose levels.

For more information, see OMIM.


E74.00 – Glycogen storage disease, unspecified

66937008 – Glycogen storage disease, type III

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required


Subscription Required

Last Updated: 03/29/2017
Copyright © 2020 VisualDx®. All rights reserved.
Glycogen storage disease type 3
Print 2 Images
View all Images (2)
(with subscription)
Glycogen storage disease type 3 (Type IIIa) : Seizures, Hepatomegaly, ALT elevated, AST elevated, Hypoglycemia, Ketoacidosis, Muscle weakness, Creatine kinase elevated, AST/ALT elevated
Copyright © 2020 VisualDx®. All rights reserved.